A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6

Journal of Biological Chemistry

Volumn 292, Issue 2, 2017, Pages 528-538

  Yasuda, Hideyo ^a,b   Oh, Chun Do ^b,c   Chen, Di ^c   De Crombrugghe, Benoit ^b   Kim, Jin Hoi ^a  

^a Konkuk University   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BINS; COLLAGEN; ELECTROPHORETIC MOBILITY; GENES; MOLECULAR BIOLOGY;

CARTILAGINOUS TISSUES; CHONDROSARCOMA CELLS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MECHANISM OF ACTION; REGULATORY MECHANISM; TRANSCRIPTION START SITE; TRANSIENT TRANSFECTION; TYPE II COLLAGENS;

TRANSCRIPTION;

COLLAGEN TYPE 2; CRISPR ASSOCIATED PROTEIN; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; COL2A1 PROTEIN, HUMAN; COL2A1 PROTEIN, MOUSE; COL2A1 PROTEIN, RAT; SOX5 PROTEIN, HUMAN; SOX5 PROTEIN, MOUSE; SOX6 PROTEIN, HUMAN; SOX6 PROTEIN, MOUSE; SOX9 PROTEIN, HUMAN; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MUTANT; CHONDROCYTE; CHONDROSARCOMA CELL LINE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DELETION MUTANT; DNA BINDING; DNA SEQUENCE; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENOME; HUMAN; HUMAN CELL; INTRON; LUCIFERASE ASSAY; MRNA EXPRESSION ASSAY; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLLAGEN TYPE II; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; INTRONS; MICE; RATS; SOX9 TRANSCRIPTION FACTOR; SOXD TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 85009726423     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.758425     Document Type: Article

References (34)

1. Benko, S., Fantes, J. A., Amiel, J., Kleinjan, D. J., Thomas, S., Ramsay, J., Jamshidi, N., Essafi, A., Heaney, S., Gordon, C. T., McBride, D., Golzio, C., Fisher, M., Perry, P., Abadie, V., et al. (2009) Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat. Genet. 41, 359-364
2. Bi, Q., Zhang, J., Huang, Y., Su, H., Zhou, X., and Zhu, S. (2001) Construction, expression, and characterization of recombinant hirudin in Escherichia coli. Appl. Biochem. Biotechnol. 95, 23-30
3. Kist, R., Schrewe, H., Balling, R., and Scherer, G. (2002) Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis 32, 121-123
4. Foster, J. W., Dominguez-Steglich, M. A., Guioli, S., Kwok, C., Weller, P. A., Stevanović, M., Weissenbach, J., Mansour, S., Young, I. D., and Goodfellow, P. N. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530
5. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E., Wolf, U., Tommerup, N., Schempp, W., and Scherer, G. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120
6. Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A., and de Crombrugghe, B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813-2828
7. Oh, C. D., Lu, Y., Liang, S., Mori-Akiyama, Y., Chen, D., de Crombrugghe, B., and Yasuda, H. (2014) SOX9 regulates multiple genes in chondrocytes, including genes encoding ECM proteins, ECM modification enzymes, receptors, and transporters. PloS ONE 9, e107577
8. Oh, C. D., Lu, Y., Liang, S., Mori-Akiyama, Y., Chen, D., de Crombrugghe, B., and Yasuda, H. (2015) Correction: SOX9 regulates multiple genes in chondrocytes, including genes encoding ECM proteins, ECM modification enzymes, receptors, and transporters. PloS ONE 10, e0143156
9. Oh, C. D., Maity, S. N., Lu, J. F., Zhang, J., Liang, S., Coustry, F., de Crombrugghe, B., and Yasuda, H. (2010) Identification of SOX9 interaction sites in the genome of chondrocytes. PloS ONE 5, e10113
10. Vandenberg, P., Khillan, J. S., Prockop, D. J., Helminen, H., Kontusaari, S., and Ala-Kokko, L. (1991) Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc. Natl. Acad. Sci. U.S.A. 88, 7640-7644
11. Forzano, F., Lituania, M., Viassolo, A., Superti-Furga, V., Wildhardt, G., Zabel, B., and Faravelli, F. (2007)Afamilial case of achondrogenesis type II caused by a dominant COL2A1 mutation and "patchy" expression in the mosaic father. Am. J. Med. Genet. A 143A, 2815-2820
12. Richards, A. J., Martin, S., Yates, J. R., Scott, J. D., Baguley, D. M., Pope, F. M., and Snead, M. P. (2000) COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes. Br. J. Ophthalmol. 84, 364-371
13. Su, P., Li, R., Liu, S., Zhou, Y., Wang, X., Patil, N., Mow, C. S., Mason, J. C., Huang, D., and Wang, Y. (2008) Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calve-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1. Arthritis Rheum. 58, 1701-1706
14. Bernard, P., Tang, P., Liu, S., Dewing, P., Harley, V. R., and Vilain, E. (2003) Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 12, 1755-1765
15. Coustry, F., Oh, C. D., Hattori, T., Maity, S. N., de Crombrugghe, B., and Yasuda, H. (2010) The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template. Nucleic Acids Res. 38, 6018-6028
16. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N., and de Crombrugghe, B. (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro-1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346
17. Lefebvre, V., Zhou, G., Mukhopadhyay, K., Smith, C. N., Zhang, Z., Eberspaecher, H., Zhou, X., Sinha, S., Maity, S. N., and de Crombrugghe, B. (1996) An 18-base-pair sequence in the mouse pro-1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell. Biol. 16, 4512-4523
18. Mukhopadhyay, K., Lefebvre, V., Zhou, G., Garofalo, S., Kimura, J. H., and de Crombrugghe, B. (1995) Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro--1(II) collagen gene. J. Biol. Chem. 270, 27711-27719
19. Bell, D. M., Leung, K. K., Wheatley, S. C., Ng, L. J., Zhou, S., Ling, K. W., Sham, M. H., Koopman, P., Tam, P. P., and Cheah, K. S. (1997) SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174-178
20. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R., and de Crombrugghe, B. (1999) Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89
21. Liu, C. F., and Lefebvre, V. (2015) The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis. Nucleic Acids Res. 43, 8183-8203
22. Ohba, S., He, X., Hojo, H., and McMahon, A. P. (2015) Distinct transcriptional programs underlie Sox9 regulation of the mammalian chondrocyte. Cell Rep. 12, 229-243
23. Lefebvre, V., Li, P., and de Crombrugghe, B. (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733
24. Shinomura, T., Ito, K., Höök, M., and Kimura, J. H. (2012) A newly identified enhancer element responsible for type II collagen gene expression. J. Biochem. 152, 565-575
25. Hattori, T., Kishino, T., Stephen, S., Eberspaecher, H., Maki, S., Takigawa, M., de Crombrugghe, B., and Yasuda, H. (2013) E6-AP/UBE3A protein acts as a ubiquitin ligase toward SOX9 protein. J. Biol. Chem. 288, 35138-35148
26. Fabian, M. R., Sonenberg, N., and Filipowicz, W. (2010) Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379
27. Hattori, T., Coustry, F., Stephens, S., Eberspaecher, H., Takigawa, M., Yasuda, H., and de Crombrugghe, B. (2008) Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res. 36, 3011-3024
28. Kawakami, Y., Tsuda, M., Takahashi, S., Taniguchi, N., Esteban, C. R., Zemmyo, M., Furumatsu, T., Lotz, M., Izpisúa Belmonte, J. C., and Asahara, H. (2005) Transcriptional coactivator PGC-1- regulates chondrogenesis via association with Sox9. Proc. Natl. Acad. Sci. U.S.A. 102, 2414-2419
29. Takigawa, Y., Hata, K., Muramatsu, S., Amano, K., Ono, K., Wakabayashi, M., Matsuda, A., Takada, K., Nishimura, R., and Yoneda, T. (2010) The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9. J. Cell Sci. 123, 3780-3788
30. Nakamura, Y., Yamamoto, K., He, X., Otsuki, B., Kim, Y., Murao, H., Soeda, T., Tsumaki, N., Deng, J. M., Zhang, Z., Behringer, R. R., Crombrugghe, B. d., Postlethwait, J. H., Warman, M. L., Nakamura, T., and Akiyama, H. (2011) Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat. Commun. 2, 251
31. Hattori, T., Eberspaecher, H., Lu, J., Zhang, R., Nishida, T., Kahyo, T., Yasuda, H., and de Crombrugghe, B. (2006) Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J. Biol. Chem. 281, 14417-14428
32. Han, Y., and Lefebvre, V. (2008) L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol. Cell. Biol. 28, 4999-5013
33. Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., and Zhang, F. (2013) Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308
34. Yasuda, H., Kim, E., Reza, A. M. M. T., and Kim, J.-H. (2016) A highly efficient method for enriching TALEN or CRISPR/Cas9-edited mutant cells. J. Genet. Genomics 10.1016/j.jgg.2016.10.006